LAVA Medtech Acquisition Corp. (NASDAQ:LVAC – Get Rating) was the recipient of a significant decline in short interest in the month of August. As of August 15th, there was short interest totalling 300 shares, a decline of 85.0% from the July 31st total of 2,000 shares. Based on an average daily trading volume, of 16,600 shares, the short-interest ratio is currently 0.0 days.
LAVA Medtech Acquisition Stock Performance
Shares of LVAC remained flat at $10.05 during trading hours on Friday. LAVA Medtech Acquisition has a 12-month low of $9.83 and a 12-month high of $10.07. The stock's 50-day moving average price is $10.02 and its 200 day moving average price is $9.98.
Get LAVA Medtech Acquisition alerts:Institutional Trading of LAVA Medtech Acquisition
Several large investors have recently modified their holdings of LVAC. Glazer Capital LLC bought a new stake in shares of LAVA Medtech Acquisition in the first quarter worth about $264,000. Starboard Value LP bought a new stake in shares of LAVA Medtech Acquisition in the fourth quarter worth about $474,000. Walleye Trading LLC bought a new stake in LAVA Medtech Acquisition during the 1st quarter valued at approximately $539,000. Walleye Capital LLC bought a new stake in LAVA Medtech Acquisition during the 1st quarter valued at approximately $658,000. Finally, Fifth Lane Capital LP bought a new stake in LAVA Medtech Acquisition during the 4th quarter valued at approximately $986,000. 31.65% of the stock is owned by institutional investors.
About LAVA Medtech Acquisition
(Get Rating)LAVA Medtech Acquisition Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company focuses on pursuing opportunities in healthcare and healthcare-related industries.
Read More
- Get a free copy of the StockNews.com research report on LAVA Medtech Acquisition (LVAC)
- Why This Dip in Advanced Auto Parts May be an Opportunity
- MarketBeat: Week in Review 8/22 – 8/26
- Institutional Buying Put A Bottom In Marvell Technology
- Dell Stock Retreats On Weaker Sales, Falls Into Value Terrirtory
- 3 Reasons Dollar General's Rally Has Legs
Receive News & Ratings for LAVA Medtech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LAVA Medtech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.